Comparative effectiveness of lenalidomide/dexamethasone-based triplet regimens for treatment of relapsed and/or refractory multiple myeloma in the United States: An analysis of real-world electronic health records data.
Saved in:
| Title: | Comparative effectiveness of lenalidomide/dexamethasone-based triplet regimens for treatment of relapsed and/or refractory multiple myeloma in the United States: An analysis of real-world electronic health records data. |
|---|---|
| Authors: | Ailawadhi S; Mayo Clinic, Jacksonville, FL 32224, USA., Cheng M; Analysis Group, Inc., Boston, MA 02199, USA. Electronic address: Mu.Cheng@analysisgroup.com., Cherepanov D; Takeda Development Center Americas, Inc., Lexington, MA 02421, USA., DerSarkissian M; Analysis Group, Inc., Boston, MA 02199, USA., Stull DM; Takeda Development Center Americas, Inc., Lexington, MA 02421, USA., Hilts A; Analysis Group, Inc., Boston, MA 02199, USA., Chun J; Analysis Group, Inc., Boston, MA 02199, USA., Duh MS; Analysis Group, Inc., Boston, MA 02199, USA., Sanchez L; Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. |
| Source: | Current problems in cancer [Curr Probl Cancer] 2024 Jun; Vol. 50, pp. 101078. Date of Electronic Publication: 2024 Mar 27. |
| Publication Type: | Journal Article; Comparative Study; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Mosby Country of Publication: United States NLM ID: 7702986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-6345 (Electronic) Linking ISSN: 01470272 NLM ISO Abbreviation: Curr Probl Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
